Microsoft retires Defender endpoint data alerting, requiring organizations to switch to Purview DLP to avoid losing ...

What it is. AXPAXLI (OTX-TKI) is an investigational, bioresorbable intravitreal hydrogel implant designed to continuously ...

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On track ...

The Environmental Protection Agency has awarded $1.9 million to a researcher at the University of Arkansas to study the ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or ...

The amount of heat being trapped by the Earth reached a record high in 2025, according to the United Nations, with scientists ...

Researchers scanning satellite images of West Antarctica stumbled onto clusters of emperor penguins gathered on fast ice to ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...

Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared ...

Cornell scientists have engineered E. coli to act as a sensitive biosensor for monitoring environmental arsenic, a toxic ...

Infineon’s XDPE1E multiphase PWM buck controllers and TDA49720/12/06 PMBus POL regulators streamline voltage regulation in AI ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...